BriMindInvest Logo

BMRN (BMRN) Stock Analysis 2026

$65.61
as of 2026-08-26

BriMind AI Score

Proprietary
27
Weak
Price CAGR
-3.5%
1Y Return
+13.9%
Analyst Upside
+36.5%
Rev Growth
19.9%

Score based on historical price CAGR, revenue growth, analyst upside, and valuation factors. Updated daily.

BriMind 1-Year Price Target

$73.00+11.3% potential
Bear Case
$49.94
Bull Case
$96.01
Model Confidence90%

BriMind AI combines DCF, momentum, and analyst consensus to project a 12-month price target.

AI scores and price targets are for informational and educational purposes only. They do not constitute financial advice or a recommendation to buy or sell any security. Past performance is not indicative of future results. Always conduct your own research before making investment decisions. Full Disclaimer →

Compare BMRN with Peers

BMRN vs ALNYBioMarin vs Alnylam — Which Rare Disease Biotech Is Bet
SRPT vs BMRNSarepta vs BioMarin — Gene Therapy Leaders for Rare Mus
VRTX vs BMRNVertex vs BioMarin — Rare Disease Leaders Compared
PTCT vs BMRNPTC Therapeutics vs BioMarin — Rare Disease Specialists

Unlock the Full BMRN Analysis

Interactive price charts, real-time AI signals, advanced DCF models, portfolio tracking, earnings analysis, and side-by-side peer comparisons. Start your 14-day free trial — no credit card required.

Start Free TrialBrowse All Stocks
Data sources: Financial metrics and market data sourced from company SEC filings, earnings releases, and investor relations disclosures. Price data, analyst consensus targets, and fundamental financials provided by financial market data providers. ETF data sourced from official fund prospectuses and index provider publications. AI scores and price targets are proprietary estimates — see our Methodology and Disclaimer for details.
← Back to Home · Browse All Stock Analysis